We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

65 hedge funds and large institutions have $231M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2013 Q2 according to their latest regulatory filings, with 65 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+65
Holders Change %
–
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
65
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$58.5M +$49.5M +2,163,235 New
Jennison Associates
2
Jennison Associates
New York
$32.2M +$27.2M +1,190,697 New
PHS
3
PFM Health Sciences
California
$30.2M +$25.5M +1,115,971 New
Massachusetts Financial Services
4
Massachusetts Financial Services
Massachusetts
$12.9M +$10.9M +477,877 New
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$11.5M +$9.73M +425,000 New
Capital World Investors
6
Capital World Investors
California
$8.79M +$7.44M +325,000 New
BFA
7
BlackRock Fund Advisors
California
$6.87M +$5.81M +253,879 New
BCM
8
BBT Capital Management
Texas
$6.12M +$5.18M +226,243 New
PC
9
Polar Capital
United Kingdom
$5.41M +$4.58M +200,000 New
IA
10
Investor AB
Sweden
$4.73M +$4M +175,000 New
BBA
11
Baker Bros. Advisors
New York
$4.46M +$3.78M +165,000 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$4.24M +$3.59M +156,875 New
BIT
13
BlackRock Institutional Trust
California
$3.22M +$2.73M +119,108 New
Allianz Asset Management
14
Allianz Asset Management
Germany
$3.18M +$2.69M +117,685 New
AGA
15
Altrinsic Global Advisors
Connecticut
$3.06M +$2.59M +113,154 New
RG
16
Redmile Group
California
$2.98M +$2.52M +110,118 New
AC
17
Ascend Capital
California
$2.94M +$2.48M +108,501 New
SCA
18
SAC Capital Advisors
Connecticut
$2.71M +$2.29M +100,000 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$2.58M +$2.19M +95,537 New
Northern Trust
20
Northern Trust
Illinois
$2.51M +$2.13M +92,909 New
PAI
21
Palo Alto Investors
California
$2.33M +$1.97M +86,201 New
Millennium Management
22
Millennium Management
New York
$2.03M +$1.72M +75,110 New
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$2.02M +$1.71M +74,800 New
State Street
24
State Street
Massachusetts
$2.02M +$1.71M +74,746 New
TCIM
25
TIAA CREF Investment Management
New York
$1.11M +$942K +41,147 New
1
2 3

KYTH Hedge Fund Activity: Q2 2013 in Review

65 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q2 2013, worth a combined $231M.

Buyers outnumbered sellers: 65 funds opened new KYTH positions and 0 closed out — a net gain of 65 holders — while 0 added to existing stakes and 0 trimmed.

  • 65 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $231M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q2 2013.
  • 65 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q2 2013 and 0 closed out, a net change of +65 holders.

Based on aggregated 13F filings for Q2 2013.